The objection policy regarding pharmaceutical sector decisions pertains to the mechanism through which individuals or companies can submit objections to decisions made by regulatory authorities in the pharmaceutical sector, such as decisions related to drug pricing, product registration, or quality control. The key elements of the objection policy include:
Competent Authorities: Objections are submitted to the relevant authorities such as the Saudi Food and Drug Authority or the Ministry of Hea...